FolioObs › TOWER SEMICONDUCTOR LTD (TSEM) › Earnings calls

TOWER SEMICONDUCTOR LTD earnings calls

TSEM · every analyst question and management's answer

Aug 4, 2026 earnings call — Japan silicon photonics capacity expansion and records

They guided third-quarter midrange revenue to be $520 million, representing an annualized revenue run rate of above $2 billion.

Revenue $0.5B (est $0.5B) · EPS $0.88 (est $0.76) · Next-quarter revenue outlook $0.5B

Key quotes

"3 weeks ago, we announced a dual-track 300-millimeter capacity strategic expansion in Japan for our silicon photonics, silicon germanium and advanced optical packaging capabilities, having gained the support of the Government of Japan through the Ministry of Economics, Trade and Industry, METI."

— Russell Ellwanger (CEO) · Japan dual-track expansion

"Under the updated model, we target $3.6 billion in annual revenue, which is $760 million higher than the February model target, reflecting 27% revenue increase."

— Oren Shirazi (CFO) · Updated 2028 model

"We announced customer contracts representing approximately $1.3 billion of silicon photonics revenue for 2027 with even higher growth for 2028."

— Russell Ellwanger (CEO) · Customer demand and bookings

Analyst Q&A 5

Japan capacity, bookings, and growth outlook

Q (Cody Grant Acree · Benchmark StoneX): He asked if the SiPho bookings number for 2027 (the $1.3 billion) was updated and whether current visibility lets them sustain or accelerate growth. He also asked about the scale and timing of the Japan Track 1 and Track 2 projects and whether the 4x includes Fab 6.

A: Management said they did not update the $1.3 billion bookings number and clarified the Q4 start rate equals 3x the Q2 shipment (680 times 3 as capacity). They expect to reach the 2028 financial model run rate (stated as $3.6 billion in the script) and said Track 1 assumes 85% utilization. Track 2 is planned to quadruple 300-millimeter capacity, budgets are approved, target tool install and function by Q4 2028, and the 4x includes Fab 6.

"I stated in the script that the Q4 start rate, which would be fully realized in Q2 '27 revenue was 3x higher than the Q2 shipment." — Russell Ellwanger (CEO)

NPO impact and manufacturing footprint

Q (Mehdi Hosseini · SIG): He asked if NPO products increase content per transceiver or create synergy with stacked PICs, and whether U.S. customers will be mainly served from Japan or U.S. sites. He also asked when RF mobile revenue would stabilize as they move to 300-millimeter.

A: Management said selling NPO does not increase content per transceiver in the way asked; NPO would often be sold instead of pluggable and sometimes both, while true PIC stacking for next-generation would be positive and centers on advanced packaging (die-to-wafer and wafer-to-wafer bonding). They said Phase 1 focuses on SiPho expansion and SiGe growth is more in Phase 2; they are increasing capacity in Newport Beach and San Antonio while Japan gives geopolitical neutrality and high-quality workforce. On RF mobile, they would not call it "stabilize" but expect Fab 10 to be very full by Q2–Q3 of next year with the largest 300-millimeter RFSOI manufacturing they've done.

"To the extent I understand your question, I would say no." — Russell Ellwanger (CEO)

200mm vs 300mm mix, NPO, and packaging role

Q (Richard Shannon · Craig-Hallum Capital Group): He asked how much of capacity after Track 2 will be 200-millimeter versus 300-millimeter, how meaningful NPO will be to SiPho revenue in 2027, and how much of SiPho revenue will be packaging-related long term.

A: Management said by mid '27–mid '28 most growth in SiGe and especially SiPho will be on 300-millimeter. They intend to add at least 20,000–25,000 wafer per month silicon photonics capacity (which could go higher) and said the predominant portion of the 4x growth will be silicon photonics, then silicon germanium. On NPO, they said it will be significant — not single digits but in the tens of percent of shipments, especially in the second half of 2027. For packaging, they said packaging will be an enabler rather than a separated packaging revenue line; they expect several tens of millions of revenue next year from integrated laser (chip-to-wafer bonding) and will bring that capability in-house.

"As a minimum, we would intend to be adding 20,000, 25,000 wafer per month silicon photonics capacity, that can go much, much higher than that." — Russell Ellwanger (CEO)

Industry capacity additions and differentiation

Q (Cody Grant Acree · Benchmark StoneX): He asked how to view industry supply/demand given peers adding capacity over the next 12–24 months and what metric best shows Tower's leadership.

A: Management said supply is increasing but they hold strong customer qualifications and contracts through '28 and focus on keeping full or majority share with lead customers. They emphasized speed and multi-generation programs, often with exclusivity that gives lead customers a head start. For differentiation, they pointed to technical figures of merit — especially insertion loss — and leadership in next-generation development.

"Insertion loss is probably one of the biggest things that one could look for." — Russell Ellwanger (CEO)

Supply chain and biggest model risk

Q (Lisa Thompson · Zacks Investment): She asked if they have any material shortages, mentioning indium phosphide, and which assumptions create the most variability in their business model (expenses, timing, or prices).

A: Management said big picture they have no broad supply shortages; they were under a crunch for indium phosphide but addressed it with a contract with IQE and multiple steps to increase substrates. Oren said the model relies on several key assumptions: selling price per wafer, cost and timing of installation and qualification, and 85% fab utilization — and that selling price per wafer usually has the biggest range of outcome because price flows directly to margin.

"Usually per wafer because if you have more or less quantity, so you have more or less variable costs associated with that." — Oren Shirazi (CFO)

AI-generated notes on the earnings call transcript. Quotes are taken from the transcript. This is not a FolioObs investment view.

TOWER SEMICONDUCTOR LTD (TSEM) · Earnings calendar

FolioObs Features | 주요 기능

  • Dashboard — SEC 13F Portfolio Tracker, FolioObs 50 | 대시보드
  • AI Insights — Portfolio Analysis & Signals | AI 인사이트
  • Insider Trading — SEC Form 4 Tracker | 내부자 거래
  • Cathie Wood Today's Trades + AI Insights | 캐시 우드 오늘의 매매
  • ARK Invest Report — Daily Trades | ARK 리포트
  • Investment News — Data-Driven Updates | 뉴스
  • Weekly Report — Market Movers | 주간 리포트
  • How to Read a 13F — 5-Minute Guide | 13F 읽는 법
  • The FolioObs 50 — All Tracked Investors | FolioObs 50 전체 보기
  • Wall Street Consensus — Shared Holdings | 월가 컨센서스
  • US Politician Trades — STOCK Act | 정치인 매매 추적
  • Earnings Calendar | 실적 발표 캘린더

FolioObs 50 | 추적 중인 월가 투자자 50인

  • Warren Buffett — Berkshire Hathaway | 워렌 버핏
  • Cathie Wood — ARK Invest | 캐시 우드
  • Stanley Druckenmiller — Duquesne Family Office | 스탠리 드러켄밀러
  • Ray Dalio — Bridgewater Associates | 레이 달리오
  • George Soros — Soros Fund Management | 조지 소로스
  • Bill Ackman — Pershing Square Capital | 빌 애크먼
  • David Tepper — Appaloosa Management | 데이비드 테퍼
  • Chase Coleman — Tiger Global Management | 체이스 콜먼
  • Dan Loeb — Third Point | 댄 로엡
  • Seth Klarman — Baupost Group | 세스 클라만
  • National Pension Service (NPS) — Korea National Pension Service | 국민연금
  • David Einhorn — Greenlight Capital | 데이비드 아인혼
  • John Paulson — Paulson & Co | 존 폴슨
  • Howard Marks — Oaktree Capital Management | 하워드 막스
  • Leon Cooperman — Omega Family Office | 레온 쿠퍼먼
  • Ken Griffin — Citadel | 켄 그리핀
  • Steve Cohen — Point72 Asset Management | 스티브 코헨
  • Li Lu — Himalaya Capital | 리 루
  • Mohnish Pabrai — Pabrai Investment Funds | 모니시 파브라이
  • Bruce Berkowitz — Fairholme Capital Management | 브루스 버코비츠
  • Nelson Peltz — Trian Fund Management | 넬슨 펠츠
  • Carl Icahn — Icahn Capital | 칼 아이칸
  • Paul Singer — Elliott Management | 폴 싱어
  • Philippe Laffont — Coatue Management | 필립 라퐁
  • Andreas Halvorsen — Viking Global | 안드레아스 할보르센
  • Daniel Sundheim — D1 Capital | 다니엘 선드하임
  • Masayoshi Son — SoftBank Group | 손정의
  • Terry Smith — Fundsmith | 테리 스미스
  • Joel Greenblatt — Gotham Asset Management | 조엘 그린블랫
  • Bill Miller — Miller Value Partners | 빌 밀러
  • Brad Gerstner — Altimeter Capital | 브래드 거스트너
  • Rajiv Jain — GQG Partners | 라지브 자인
  • Duan Yongping — H&H International | 돤융핑
  • Chris Hohn — TCI Fund Management | 크리스 혼
  • Stephen Mandel — Lone Pine Capital | 스티븐 만델
  • Prem Watsa — Fairfax Financial | 프렘 왓사
  • Sequoia Fund — Ruane Cunniff & Goldfarb | 세쿼이아 펀드
  • Guy Spier — Aquamarine Capital | 가이 스파이어
  • Lee Ainslie — Maverick Capital | 리 아인슬리
  • David Abrams — Abrams Capital | 데이비드 아브람스
  • Pat Dorsey — Dorsey Asset Management | 팻 도시
  • Dev Kantesaria — Valley Forge Capital | 데브 칸테사리아
  • Francois Rochon — Giverny Capital | 프랑수아 로숑
  • Thomas Russo — Gardner Russo & Quinn | 토마스 루소
  • Tweedy Browne — Tweedy Browne | 트위디 브라운
  • Temasek — Temasek Holdings | 테마섹
  • Saudi PIF — Public Investment Fund | 사우디 국부펀드
  • Baillie Gifford — Baillie Gifford | 베일리 기포드
  • Ron Baron — Baron Capital | 론 배런
  • Thomas Gayner — Markel Group | 토마스 게이너